Class II Recall: GEM Premier 5000 PAKs due to PCSND Errors
Summary
The FDA has issued a Class II recall for Instrumentation Laboratory's GEM Premier 5000 PAKs (Part No. 00055407508) due to an increased incidence of Process Control Solution Not Detected (PCSND) errors. The recall is ongoing and has worldwide distribution.
What changed
The FDA has classified a recall of GEM Premier 5000 PAKs (cartridges) as Class II, indicating that the use of or exposure to a defective product may cause adverse health consequences that are reversible or temporary. The issue stems from an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, leading to GEM PAK ejection. This recall affects product part number 00055407508.
Healthcare providers using the GEM Premier 5000 system should be aware of this recall and monitor for PCSND errors. While the recall is ongoing and distribution is worldwide, specific actions for providers are not detailed in this notice. The FDA's classification suggests that while adverse events are possible, they are likely reversible or temporary, but vigilance is advised to ensure proper device function and patient safety.
What to do next
- Review internal procedures for monitoring GEM Premier 5000 PAK performance.
- Ensure staff are aware of potential PCSND errors and GEM PAK ejection issues.
- Consult manufacturer documentation for troubleshooting steps related to PCSND errors.
Source document (simplified)
Instrumentation Laboratory
Device Recalls (Class II)
← All Device Recalls (Class II) Class II Z-1529-2026 · 20260318 · Ongoing
Product
GEM Premier 5000 PAK; Part No. 00055407508.
Reason for Recall
Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...
Distribution
Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...
Source: openFDA Enforcement API
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FDA: Device Recalls Class II publishes new changes.